Evaluation of a Biopsy Gun for Guided Biopsy of Impalpable Liver Lesions Using Intraoperative Utrasound

por Charnley, R. M., Sheffield, J. P., Hardcastle, J. D.
Publicado 1990

Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.

por Thomas, W. M., Hardcastle, J. D., Jackson, J., Pye, G.
Publicado 1992

Screening and the costs of treating colorectal cancer.

por Whynes, D. K., Walker, A. R., Chamberlain, J. O., Hardcastle, J. D.
Publicado 1993

Failure of CA19-9 to detect asymptomatic colorectal carcinoma.

por Thomas, W. M., Robertson, J. F., Price, M. R., Hardcastle, J. D.
Publicado 1991

A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.

por Armitage, N., Hardcastle, J. D., Amar, S. S., Balfour, T. W., Haynes, J., James, P. D.
Publicado 1985

Colorectal adenomas and energy intake, body size and physical activity: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

por Little, J., Logan, R. F., Hawtin, P. G., Hardcastle, J. D., Turner, I. D.
Publicado 1993

Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

por Little, J., Logan, R. F., Hawtin, P. G., Hardcastle, J. D., Turner, I. D.
Publicado 1993

The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR).

por Rooney, P. S., Clarke, P. A., Gifford, K. A., Hardcastle, J. D., Armitage, N. C.
Publicado 1993

The effect of calcium supplements on rectal mucosal proliferation.

por Armitage, N. C., Rooney, P. S., Gifford, K. A., Clarke, P. A., Hardcastle, J. D.
Publicado 1995

The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.

por Robertson, J. F., Morris, D. L., Ellis, I. O., Armitage, N. C., Hardcastle, J. D.
Publicado 1991

Flow cytometric analysis of the DNA content of gastric cancer.

por Ballantyne, K. C., James, P. D., Robins, R. A., Baldwin, R. W., Hardcastle, J. D.
Publicado 1987

The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

por Armitage, N. C., Ballantyne, K. C., Evans, D. F., Clarke, P., Sheffield, J., Hardcastle, J. D.
Publicado 1990

Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen.

por Price, M. R., Pimm, M. V., Page, C. M., Armitage, N. C., Hardcastle, J. D., Baldwin, R. W.
Publicado 1984

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.

por Durrant, L. G., Robins, R. A., Ballantyne, K. C., Marksman, R. A., Hardcastle, J. D., Baldwin, R. W.
Publicado 1989

Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.

por Watson, S. A., Crosbee, D. M., Morris, D. L., Robertson, J. F., Makovec, F., Rovati, L. C., Hardcastle, J. D.
Publicado 1992

Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.

por Durrant, L. G., Ballantyne, K. C., Armitage, N. C., Robins, R. A., Marksman, R., Hardcastle, J. D., Baldwin, R. W.
Publicado 1987

Antigenicity of newly established colorectal carcinoma cell lines.

por Durrant, L. G., Robins, R. A., Pimm, M. V., Perkins, A. C., Armitage, N. C., Hardcastle, J. D., Baldwin, R. W.
Publicado 1986

Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer.

por Hunt, L. M., Robinson, M. H., Hugkulstone, C. E., Clarke, B., Vernon, S. A., Gregson, R. H., Hardcastle, J. D., Armitage, N. C.
Publicado 1994

Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

por Durrant, L. G., Garnett, M. C., Gallego, J., Armitage, N. C., Ballantyne, K. C., Marksman, R. A., Hardcastle, J. D., Baldwin, R. W.
Publicado 1987

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

por Maxwell-Armstrong, C A, Durrant, L G, Buckley, T J D, Scholefield, J H, Robins, R A, Fielding, K, Monson, J R T, Guillou, P, Calvert, H, Carmichael, J, Hardcastle, J D
Publicado 2001